Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Clinical trial NCT00641381 · COMPLETED
Trial details
- NCT number
- NCT00641381
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-05-10
- Primary completion
- 2026-02-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.